The revenue of the US sustained release coatings market demonstrates robust growth from 2020 to 2035. In 2025, the market size is estimated at USD 890 Million, up from USD 730 Million in 2021, and projected to reach USD 1,780 Million by 2035. Rising demand for advanced therapeutics and growing pharmaceutical manufacturing capacity underpins consistent revenue growth. Investments in drug innovation and partnerships across the value chain further accelerate financial expansion. As new materials and coating technologies enter the market, revenue generation is expected to see a steady CAGR through the forecast period.
Read More - https://bussinessinsights.com/research-report/us-sustained-release-coatings-market
Tablets dominate the US sustained release coatings market application share in 2025, benefiting from well-established manufacturing processes and broad prescription trends for oral dosage forms. Capsules follow, driven by increasing demand for higher patient compliance and multiple therapeutic areas. Pills and granules represent important alternative segments, particularly for children and geriatric populations. The versatility of these applications ensures sustained market relevance, supported by ongoing innovation in multi-particulate and bead-based drug delivery systems.
Request Free Sample- https://bussinessinsights.com/request/chemical-and-material/us-sustained-release-coatings-market
Who are the key players in US Sustained Release Coatings Market industry?
The top five players in the US Sustained Release Coatings Market include Colorcon Inc., BASF SE, Evonik Industries AG, DuPont de Nemours, Inc., and Ashland Global Holdings Inc. These companies are recognized for their expertise in innovative coating formulations, extensive product portfolios, and strong focus on research and development for pharmaceutical and nutraceutical applications.
What is the US Sustained Release Coatings Market growth?
The US Sustained Release Coatings Market has experienced steady growth, fueled by rising demand for controlled drug delivery systems. For example, in 2023, BASF SE reported increased sales in their pharmaceutical excipients division, driven by innovations in sustained release technologies and expanding client partnerships with pharmaceutical manufacturers.
Which segment accounted for the largest US Sustained Release Coatings Market share?
Pharmaceutical applications held the largest market share in the US Sustained Release Coatings Market. This dominance is attributed to the growing focus on patient compliance, advancements in oral drug delivery methods, and increasing adoption of sustained release formulations by leading pharmaceutical companies to improve therapeutic efficacy and reduce dosing frequency.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com